PURPOSE: Health-related quality of life (HRQOL) measures typically do not incorporate patients' preferences for domains such as physical, emotional, functional and social/family well-being, which may compromise precision. METHOD: A forced-choice domain-preference measure was developed to assess the importance of HRQOL domains. About 194 cancer patients completed the domain-preference measure, along with measures of HRQOL, coping, adjustment, and life satisfaction. RESULTS: Patients ranked emotional well-being as most important and the loss of social-family well-being as the most difficult to do without. A weighting algorithm revealed no advantage to incorporating individuals' domain preferences in HRQOL assessment; however, preliminary evidence suggested that HRQOL measurement may be more accurate in predicting outcomes for individuals with no distinct domain preferences than those with distinct preference profiles. CONCLUSION: This study provides preliminary evidence for the validity of current measures of HRQOL, which may inherently take into account patients' domain preferences.
PURPOSE: Health-related quality of life (HRQOL) measures typically do not incorporate patients' preferences for domains such as physical, emotional, functional and social/family well-being, which may compromise precision. METHOD: A forced-choice domain-preference measure was developed to assess the importance of HRQOL domains. About 194 cancerpatients completed the domain-preference measure, along with measures of HRQOL, coping, adjustment, and life satisfaction. RESULTS:Patients ranked emotional well-being as most important and the loss of social-family well-being as the most difficult to do without. A weighting algorithm revealed no advantage to incorporating individuals' domain preferences in HRQOL assessment; however, preliminary evidence suggested that HRQOL measurement may be more accurate in predicting outcomes for individuals with no distinct domain preferences than those with distinct preference profiles. CONCLUSION: This study provides preliminary evidence for the validity of current measures of HRQOL, which may inherently take into account patients' domain preferences.
Authors: D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon Journal: J Clin Oncol Date: 1993-03 Impact factor: 44.544
Authors: Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: David Osoba; Ming-Ann Hsu; Catherine Copley-Merriman; John Coombs; F Reed Johnson; Brett Hauber; Ranjani Manjunath; Amanda Pyles Journal: Qual Life Res Date: 2006-03 Impact factor: 4.147
Authors: Brenda L Den Oudsten; Jolanda De Vries; Alida F W Van der Steeg; Jan A Roukema; Guus L Van Heck Journal: Qual Life Res Date: 2009-10-28 Impact factor: 4.147